TJP1 and breast cancer: Exosomes containing miR-105 can be released by metastatic breast cancer cells to destroy the vascular endothelium barrier targeting the tight junction protein 1 (TJP1) in endothelial cells (recipient cells) and promoting cancer metastasis [87].